Document is current
Any future updates will be listed below
-
Authors
Nair, Radhika
Singh, Nishita
Kate, Mahesh https://orcid.org/0000-0003-4794-2882
Asdaghi, Negar
Sarmiento, Robert
Bala, Fouzi https://orcid.org/0000-0001-6748-2081
Coutts, Shelagh B
Horn, MacKenzie https://orcid.org/0000-0002-1472-3977
Poppe, Alexandre Y
Williams, Heather
Ademola, Ayoola
Alhabli, Ibrahim
Benali, Faysal
Khosravani, Houman
Hunter, Gary
Tkach, Aleksander
Manosalva Alzate, Herbert Alejandro https://orcid.org/0000-0001-8801-9248
Pikula, Aleksandra
Field, Thalia https://orcid.org/0000-0002-1176-0633
Trivedi, Anurag
Dowlatshahi, Dar https://orcid.org/0000-0003-1379-3612
Catanese, Luciana
Shuaib, Ashfaq https://orcid.org/0000-0002-3380-7068
Demchuk, Andrew
Sajobi, Tolulope
Almekhlafi, Mohammed A
Swartz, Richard H
Menon, Bijoy
Buck, Brian H https://orcid.org/0000-0002-7984-6062
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03889249 at ClinicalTrials.govnct02398656 at ClinicalTrials.govDocuments that mention this clinical trial
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial
https://doi.org/10.1136/svn-2023-002828
Effect of thrombolysis type on the efficacy of aspiration versus stent retriever first line thrombectomy: results from the AcT trial
https://doi.org/10.1136/jnis-2024-022268
Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial
https://doi.org/10.1161/strokeaha.123.044690
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
https://doi.org/10.1136/svn-2021-000978
Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial
https://doi.org/10.1161/strokeaha.123.044267
Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase
https://doi.org/10.1161/strokeaha.123.045320
Comparing Clinical Characteristics and Outcomes of Tenecteplase Versus Alteplase in Young Adult Patients With Stroke: A Secondary Analysis of the AcT Trial
https://doi.org/10.1161/svin.125.001974
Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial
https://doi.org/10.1161/strokeaha.124.049512
Documents that mention this clinical trial
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial
https://doi.org/10.1136/svn-2023-002828
European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischemic Stroke
https://doi.org/10.1136/neurintsurg-2018-014569
Rationale and design of ProUrokinase in Mild IsChemic strokE (PUMICE): a multicentre, prospective, randomised, open-label, blinded-endpoint controlled trial
https://doi.org/10.1136/svn-2023-002673
Advances in mechanical thrombectomy for acute ischaemic stroke from large vessel occlusions
https://doi.org/10.1136/svn-2021-000972
-
Funding
Funding for this research was provided by:
Alberta Strategy for Patient Oriented Research Support Unit (N/A)
Canadian Institutes of Health Research (419722)
Canadian Institutes of Health Research (450890)
- License Information
